Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
- Status
- COMPLETED
- Phase
- NA
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
- Status
- UNKNOWN
- Phase
- PHASE2
Meal-regulated Substrate Metabolism, Influence of Obesity and IL-6
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection
- Status
- COMPLETED
- Phase
- PHASE3
A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.
- Status
- COMPLETED
- Phase
- PHASE1
Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
- Status
- UNKNOWN
- Phase
- PHASE2
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Tocilizumab in COVID-19 Lahore General Hospital
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
- Status
- COMPLETED
- Phase
- PHASE1
Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Toclizumam Versus Dexamethasone in Severe Covid-19 Cases
- Status
- COMPLETED
- Phase
- NA
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan
- Status
- COMPLETED
- Phase
- NA
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2